Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in J Infect

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    July 2021
  1. ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
    Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
    J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
    PubMed     Abstract available


  2. FAVRESSE J, Douxfils J
    Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
    J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
    PubMed    


    June 2021
  3. HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
    Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
    PubMed    


  4. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
    PubMed    


  5. TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
    Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
    PubMed    


  6. DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
    One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
    PubMed    


  7. AKPOLAT T, Uzun O
    REDUCED MORTALITY RATE AFTER CORONAVAC VACCINE AMONG HEALTHCARE WORKERS.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00285.
    PubMed    


    May 2021
  8. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    PubMed    


  9. PEZZATI L, Giacomelli A, Mileto D, Conti F, et al
    Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: a cross-sectional study.: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
    J Infect. 2021 May 29. pii: S0163-4453(21)00271.
    PubMed    


  10. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    PubMed    


  11. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.
    PubMed    


  12. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    PubMed     Abstract available


  13. SANSONE E, Tiraboschi M, Sala E, Albini E, et al
    Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
    J Infect. 2021 May 6. pii: S0163-4453(21)00225.
    PubMed     Abstract available


    April 2021
  14. GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
    Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
    PubMed    


  15. MARTINON-TORRES F, Banzhoff A, Azzari C, De Wals P, et al
    Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination: Real-world effectiveness of MenB vaccination.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00218.
    PubMed     Abstract available


  16. DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
    Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
    J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
    PubMed    


  17. LODI L, Moriondo M, Nieddu F, Ricci S, et al
    Molecular typing of group B Neisseria meningitidis'subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period
    J Infect. 2021;82:28-36.
    PubMed     Abstract available


    February 2021
  18. ABAD R, Garcia-Amil C, Navarro C, Martin E, et al
    Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: evolution of the vaccine antigen factor H binding protein (FHbp).
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00087.
    PubMed     Abstract available


  19. BAO HL, Jin C, Wang S, Song Y, et al
    Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00084.
    PubMed     Abstract available


  20. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    PubMed     Abstract available


    December 2020
  21. ZENG H, Yi L, Chen X, Zhou H, et al
    First detection of EV-A71 genotype C1 in China Emergence of a non vaccine-cognate enterovirus A71 genotype C1 in mainland China.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30782.
    PubMed     Abstract available


    November 2020
  22. LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
    Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
    PubMed    


  23. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    PubMed    


  24. AYE AMM, Bai X, Borrow R, Bory S, et al
    Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative.
    J Infect. 2020;81:698-711.
    PubMed     Abstract available


    October 2020
  25. SUAYA JA, Mendes RE, Sings HL, Arguedas A, et al
    Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 20092017.
    J Infect. 2020;81:557-566.
    PubMed     Abstract available


  26. SMITH EL, Wheeler I, Adler H, Ferreira DM, et al
    Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors.
    J Infect. 2020;81:540-548.
    PubMed     Abstract available


    September 2020
  27. ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
    A possible role for GRP78 in cross vaccination against COVID-19.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
    PubMed    


    August 2020
  28. KINOSHITA M, Tanaka M
    Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
    PubMed     Abstract available


  29. GLATMAN-FREEDMAN A, Kaufman Z, Applbaum Y, Dichtiar R, et al
    Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017.
    J Infect. 2020;81:297-303.
    PubMed     Abstract available


  30. GOMEZ-RIAL J, Rivero-Calle I, Salas A, Martinon-Torres F, et al
    Rotavirus and autoimmunity.
    J Infect. 2020;81:183-189.
    PubMed     Abstract available


    July 2020
  31. BORROW R, Taha MK, Giuliani MM, Pizza M, et al
    Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence.
    J Infect. 2020 Jul 31. pii: S0163-4453(20)30515.
    PubMed     Abstract available


  32. NYAZIKA TK, Law A, Swarthout TD, Sibale L, et al
    Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30495.
    PubMed     Abstract available


    June 2020
  33. PARIKH S, Campbell H, Bettinger JA, Harrison LH, et al
    The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30378.
    PubMed     Abstract available


    May 2020
  34. DEGHMANE AE, Haeghebaert S, Hong E, Jousset A, et al
    Emergence of new genetic lineage, ST-9316, of Neisseria meningitidis group W in Hauts-de-France region, France 2013-2018.
    J Infect. 2020;80:519-526.
    PubMed     Abstract available


    March 2020
  35. BEEBEEJAUN K, Parikh SR, Campbell H, Gray S, et al
    Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    J Infect. 2020;80:286-290.
    PubMed     Abstract available


    February 2020
  36. JI C, Cai S, Lu G, Zhang G, et al
    Challenges to develop an equine herpesvirus vaccine in China.
    J Infect. 2020 Feb 1. pii: S0163-4453(20)30037.
    PubMed    


  37. CAMPBELL H, Andrews N, Parikh S, Ribeiro S, et al
    Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.
    J Infect. 2020;80:182-189.
    PubMed     Abstract available


    January 2020
  38. LINTON NM, Keita M, De Almeida MM, Cuesta JG, et al
    Impact of mass vaccination campaigns on measles transmission during an outbreak in Guinea, 2017.
    J Infect. 2020 Jan 17. pii: S0163-4453(20)30023.
    PubMed     Abstract available


    December 2019
  39. BERILD JD, Steens A, Winje BA, Danielsen TE, et al
    Management and control of an outbreak of vaccine-preventable severe pneumococcal disease at a shipyard in Norway.
    J Infect. 2019 Dec 28. pii: S0163-4453(19)30387.
    PubMed    


    November 2019
  40. CREW PE, McNamara L, Waldron PE, McCulley L, et al
    Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease: Antibiotic prophylaxis and eculizumab.
    J Infect. 2019 Nov 26. pii: S0163-4453(19)30353.
    PubMed    


    October 2019
  41. AMIN-CHOWDHURY Z, Iyanger N, Ramsay ME, Ladhani SN, et al
    Outbreaks of serious pneumococcal disease in closed settings in the conjugate vaccines era, 2010-2018: a systematic review to inform national guidance in the UK.
    J Infect. 2019 Oct 17. pii: S0163-4453(19)30319.
    PubMed     Abstract available


  42. MARSHALL HS, Baber J, Richmond P, Nissen M, et al
    S. aureus Colonization in Healthy Australian Adults Receiving an Investigational S. aureus 3-antigen Vaccine.
    J Infect. 2019 Oct 1. pii: S0163-4453(19)30289.
    PubMed     Abstract available


    September 2019
  43. MARKKULA J, Hemming-Harlo M, Savolainen-Kopra C, Al-Hello H, et al
    Continuing rotavirus circulation in children and adults despite high coverage rotavirus vaccination in Finland.
    J Infect. 2019 Sep 30. pii: S0163-4453(19)30280.
    PubMed     Abstract available


  44. CHANG HY, Vuong J, Hu F, Liberator P, et al
    Distribution of Neisseria meningitidis serogroup B (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure.
    J Infect. 2019 Sep 7. pii: S0163-4453(19)30272.
    PubMed     Abstract available


    April 2019
  45. GAIOTTINO J, Giovannoni G, Breuer J, Tang JW, et al
    Chronic-relapsing varicella zoster meningitis - successfully treated with varicella vaccine.
    J Infect. 2019 Apr 10. pii: S0163-4453(19)30121.
    PubMed    


    February 2019
  46. GREEN CA, Sande CJ, Scarselli E, Capone S, et al
    Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    J Infect. 2019 Feb 8. pii: S0163-4453(19)30038.
    PubMed     Abstract available


    December 2018
  47. ZHAO HM, Du R, Li CL, Ji P, et al
    Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30354.
    PubMed     Abstract available


  48. QUINN HE, Gidding HF, Marshall HS, Booy R, et al
    Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30358.
    PubMed     Abstract available


    November 2018
  49. MUSCATELLO DJ
    Redefining influenza seasonality at a global scale and aligning it to the influenza vaccine manufacturing cycle: a descriptive time series analysis.
    J Infect. 2018 Nov 23. pii: S0163-4453(18)30309.
    PubMed     Abstract available


    October 2018
  50. WILSON P, Taylor G, Knowles J, Blyth E, et al
    Missed Hepatitis B Birth Dose Vaccine Is a Risk Factor for Incomplete Vaccination at 18 and 24 Months.
    J Infect. 2018 Oct 4. pii: S0163-4453(18)30287.
    PubMed     Abstract available


    September 2018
  51. HOU G, Li J, Wang S, Cheng S, et al
    Hemagglutinin characteristics, changes in pathogenicity, and antigenic variation of highly pathogenic H7N9 avian influenza viruses in China.
    J Infect. 2018 Sep 26. pii: S0163-4453(18)30282.
    PubMed    


    August 2018
  52. O'CONNOR C, McGuinness C, Cafferty D, Cunney R, et al
    Diagnostic stewardship in the post-vaccine era: reducing demand for meningococcal and pneumococcal PCR.
    J Infect. 2018 Aug 16. pii: S0163-4453(18)30244.
    PubMed    


    May 2018
  53. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Abstract available


  54. HOFMANS D, Khodaparast L, Khodaparast L, Vanstreels E, et al
    Ses proteins as possible targets for vaccine development against Staphylococcus epidermidis infections.
    J Infect. 2018 May 9. pii: S0163-4453(18)30130.
    PubMed     Abstract available


  55. LAO TT, Sahota DS, Chan PKS
    Three Decades of Neonatal Vaccination Has Greatly Reduced Antenatal Prevalence of Hepatitis B Virus Infection Among Gravidae Covered by the Program().
    J Infect. 2018 May 6. pii: S0163-4453(18)30106.
    PubMed     Abstract available


    January 2018
  56. FABBRINI M, Rigat F, Tuscano G, Chiarot E, et al
    Functional activity of maternal and cord antibodies elicited by an investigational Group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    J Infect. 2018 Jan 25. pii: S0163-4453(18)30026.
    PubMed     Abstract available


    December 2017
  57. MARTINON-TORRES F, Carmona Martinez A, Simko R, Infante Marquez P, et al
    Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial.
    J Infect. 2017 Dec 15. pii: S0163-4453(17)30402.
    PubMed     Abstract available


  58. KAMBIRE D, Soeters HM, Ouedraogo-Traore R, Medah I, et al
    Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
    J Infect. 2017 Dec 15. pii: S0163-4453(17)30386.
    PubMed     Abstract available


    October 2017
  59. BAKER JM, Alonso WJ
    Rotavirus vaccination takes seasonal signature of childhood diarrhea back to pre-sanitation era in Brazil.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30314.
    PubMed     Abstract available


  60. ABAD R, Medina V, Farinas MDC, Martinez-Martinez L, et al
    Potential impact of the 4CMenB vaccine on oropharyngeal carriage of neisseria meningitidis.
    J Infect. 2017 Oct 5. pii: S0163-4453(17)30313.
    PubMed     Abstract available


    September 2017
  61. RONDY M, El Omeiri N, Thompson MG, Leveque A, et al
    Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.
    J Infect. 2017 Sep 18. pii: S0163-4453(17)30299.
    PubMed     Abstract available


    August 2017
  62. TANG JW, Mutuyimana J, Teo KW, Lea S, et al
    Early seasonal influenza vaccination and delayed influenza peaks - a possible cause of end-of-season outbreaks.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30259.
    PubMed     Abstract available


  63. LUCIDARME J, Lekshmi A, Parikh SR, Bray JE, et al
    Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
    J Infect. 2017;75:95-103.
    PubMed     Abstract available


    July 2017
  64. BORROW R, Caugant DA, Ceyhan M, Christensen H, et al
    Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.
    J Infect. 2017;75:1-11.
    PubMed     Abstract available


  65. SUDENGA SL, Nyitray AG, Torres BN, Silva R, et al
    Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States.
    J Infect. 2017;75:35-47.
    PubMed     Abstract available


    June 2017
  66. GERSHON AA
    Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
    J Infect. 2017;74 Suppl 1:S27-S33.
    PubMed     Abstract available


  67. PINTO MV, Merkel TJ
    Pertussis disease and transmission and host responses: insights from the baboon model of pertussis.
    J Infect. 2017;74 Suppl 1:S114-S119.
    PubMed     Abstract available


  68. PARENT DU CHATELET I, Deghmane AE, Antona D, Hong E, et al
    Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    J Infect. 2017;74:564-574.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: